Published in J Virol on January 01, 2000
Gamma interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expression. J Virol (2005) 1.71
Epigenetic regulation of latent HSV-1 gene expression. Biochim Biophys Acta (2010) 1.65
Herpes simplex virus type 1 and bovine herpesvirus 1 latency. Clin Microbiol Rev (2003) 1.62
Herpes keratitis. Prog Retin Eye Res (2012) 1.55
Herpes simplex virus type 2 (HSV-2) establishes latent infection in a different population of ganglionic neurons than HSV-1: role of latency-associated transcripts. J Virol (2006) 1.39
Herpes simplex virus type 1 promoter activity during latency establishment, maintenance, and reactivation in primary dorsal root neurons in vitro. J Virol (2001) 1.32
A5-positive primary sensory neurons are nonpermissive for productive infection with herpes simplex virus 1 in vitro. J Virol (2011) 1.30
Spontaneous reactivation of herpes simplex virus type 1 in latently infected murine sensory ganglia. J Virol (2007) 1.13
The molecular basis of herpes simplex virus latency. FEMS Microbiol Rev (2012) 1.12
Immunological control of herpes simplex virus infections. J Neurovirol (2013) 1.08
Relaxed repression of herpes simplex virus type 1 genomes in Murine trigeminal neurons. J Virol (2007) 1.08
Of mice and not humans: how reliable are animal models for evaluation of herpes CD8(+)-T cell-epitopes-based immunotherapeutic vaccine candidates? Vaccine (2011) 1.07
Towards an understanding of the herpes simplex virus type 1 latency-reactivation cycle. Interdiscip Perspect Infect Dis (2010) 1.05
Entry of herpes simplex virus type 1 (HSV-1) into the distal axons of trigeminal neurons favors the onset of nonproductive, silent infection. PLoS Pathog (2012) 1.02
Gene therapy for bladder overactivity and nociception with herpes simplex virus vectors expressing preproenkephalin. Hum Gene Ther (2009) 1.01
Tegument protein control of latent herpesvirus establishment and animation. Herpesviridae (2011) 0.98
A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation. J Gen Virol (2015) 0.93
Lytic gene expression is frequent in HSV-1 latent infection and correlates with the engagement of a cell-intrinsic transcriptional response. PLoS Pathog (2014) 0.92
Herpes simplex virus vector-mediated gene delivery of glutamic acid decarboxylase reduces detrusor overactivity in spinal cord-injured rats. Gene Ther (2009) 0.91
Tissue-specific splicing of the herpes simplex virus type 1 latency-associated transcript (LAT) intron in LAT transgenic mice. J Virol (2006) 0.91
Construction and characterization of a herpes simplex virus type I recombinant expressing green fluorescent protein: acute phase replication and reactivation in mice. Virology (2007) 0.90
Investigation of the mechanism by which herpes simplex virus type 1 LAT sequences modulate preferential establishment of latent infection in mouse trigeminal ganglia. J Virol (2009) 0.89
17-beta estradiol promotion of herpes simplex virus type 1 reactivation is estrogen receptor dependent. J Virol (2010) 0.86
LAT region factors mediating differential neuronal tropism of HSV-1 and HSV-2 do not act in trans. PLoS One (2012) 0.85
Herpes simplex virus 1 tropism for human sensory ganglion neurons in the severe combined immunodeficiency mouse model of neuropathogenesis. J Virol (2012) 0.84
Different mechanisms regulate productive herpes simplex virus 1 (HSV-1) and HSV-2 infections in adult trigeminal neurons. J Virol (2013) 0.84
Characterization of neuronal populations in the human trigeminal ganglion and their association with latent herpes simplex virus-1 infection. PLoS One (2013) 0.80
Cell type specific accumulation of the major latency-associated transcript (LAT) of herpes simplex virus type 2 in LAT transgenic mice. Virology (2009) 0.80
Overexpression of thyroid hormone receptor β1 altered thyroid hormone-mediated regulation of herpes simplex virus-1 replication in differentiated cells. J Neurovirol (2016) 0.78
Role of polycomb proteins in regulating HSV-1 latency. Viruses (2013) 0.77
De Novo Herpes Simplex Virus VP16 Expression Gates a Dynamic Programmatic Transition and Sets the Latent/Lytic Balance during Acute Infection in Trigeminal Ganglia. PLoS Pathog (2016) 0.76
Immune Escape via a Transient Gene Expression Program Enables Productive Replication of a Latent Pathogen. Cell Rep (2017) 0.75
Adeno-associated Virus Vectors Efficiently Transduce Mouse and Rabbit Sensory Neurons Coinfected with Herpes Simplex Virus 1 following Peripheral Inoculation. J Virol (2016) 0.75
Neurotrophic Factors NGF, GDNF and NTN Selectively Modulate HSV1 and HSV2 Lytic Infection and Reactivation in Primary Adult Sensory and Autonomic Neurons. Pathogens (2017) 0.75
A complex formed between cell components and an HSV structural polypeptide binds to a viral immediate early gene regulatory DNA sequence. Cell (1988) 4.68
Herpes simplex virus 1 mutant deleted in the alpha 22 gene: growth and gene expression in permissive and restrictive cells and establishment of latency in mice. J Virol (1985) 4.17
Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site-dependent establishment and reactivation from latency. J Virol (1992) 3.56
The octamer-binding proteins form multi-protein--DNA complexes with the HSV alpha TIF regulatory protein. EMBO J (1989) 3.42
Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. Proc Natl Acad Sci U S A (1989) 3.26
Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc Natl Acad Sci U S A (1991) 3.22
A herpes simplex virus transcript abundant in latently infected neurons is dispensable for establishment of the latent state. Virology (1988) 3.11
The herpes simplex virus type 1 latency-associated transcript gene regulates the establishment of latency. J Virol (1997) 2.55
The promoter of the latency-associated transcripts of herpes simplex virus type 1 contains a functional cAMP-response element: role of the latency-associated transcripts and cAMP in reactivation of viral latency. Proc Natl Acad Sci U S A (1991) 2.47
Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. J Clin Invest (1993) 2.42
A LAT-associated function reduces productive-cycle gene expression during acute infection of murine sensory neurons with herpes simplex virus type 1. J Virol (1997) 2.35
Herpes simplex virus type 1 DNA replication and gene expression during explant-induced reactivation of latently infected murine sensory ganglia. J Virol (1994) 2.27
Herpes simplex virus latent RNA (LAT) is not required for latent infection in the mouse. Proc Natl Acad Sci U S A (1989) 2.05
A herpes simplex virus type 1 mutant containing a deletion within immediate early gene 1 is latency-competent in mice. J Gen Virol (1989) 1.98
Correlation between herpes simplex virus type 1 rate of reactivation from latent infection and the number of infected neurons in trigeminal ganglia. Virology (1996) 1.96
Pathways of viral gene expression during acute neuronal infection with HSV-1. Virology (1992) 1.81
In situ DNA PCR and RNA hybridization detection of herpes simplex virus sequences in trigeminal ganglia of latently infected mice. Virology (1995) 1.77
Nerve growth factor-dependence of herpes simplex virus latency in peripheral sympathetic and sensory neurons in vitro. J Neurosci (1990) 1.69
A monoclonal antibody against neurofilament protein specifically labels a subpopulation of rat sensory neurones. J Comp Neurol (1984) 1.63
Does nitric oxide play a critical role in viral infections? J Virol (1998) 1.62
TrkA cross-linking mimics neuronal responses to nerve growth factor. Mol Biol Cell (1994) 1.56
Interferon-gamma induced type I nitric oxide synthase activity inhibits viral replication in neurons. J Neuroimmunol (1996) 1.51
Divergent molecular pathways of productive and latent infection with a virulent strain of herpes simplex virus type 1. J Virol (1991) 1.50
Latent infection can be established with drastically restricted transcription and replication of the HSV-1 genome. Virology (1993) 1.48
Herpes simplex virus type 1 latency-associated transcripts suppress viral replication and reduce immediate-early gene mRNA levels in a neuronal cell line. J Virol (1998) 1.40
Restricted expression of herpes simplex virus lytic genes during establishment of latent infection by thymidine kinase-negative mutant viruses. J Virol (1990) 1.35
The octamer-binding protein Oct-2 represses HSV immediate-early genes in cell lines derived from latently infectable sensory neurons. Neuron (1991) 1.34
Lactoseries carbohydrates specify subsets of dorsal root ganglion neurons projecting to the superficial dorsal horn of rat spinal cord. J Neurosci (1985) 1.30
Herpes simplex viral infection of the mouse trigeminal ganglion. Immunohistochemical analysis of cell populations. Invest Ophthalmol Vis Sci (1992) 1.23
Monoclonal antibodies against carbohydrate differentiation antigens identify subsets of primary sensory neurones. Nature (1984) 1.22
Investigation of herpes simplex virus type 1 (HSV-1) gene expression and DNA synthesis during the establishment of latent infection by an HSV-1 mutant, in1814, that does not replicate in mouse trigeminal ganglia. J Gen Virol (1991) 1.21
Activation of second-messenger pathways reactivates latent herpes simplex virus in neuronal cultures. Virology (1992) 1.20
Decreased reporter gene expression during latent infection with HSV LAT promoter constructs. Virology (1993) 1.12
Neurotrophins cause a new sensation. Neuron (1996) 1.11
Specific effect of interferon on the herpes simplex virus type 1 transactivation event. J Virol (1990) 1.10
Effect of the transcription start region of the herpes simplex virus type 1 latency-associated transcript promoter on expression of productively infected neurons in vivo. J Virol (1994) 1.08
Detection of herpes simplex virus type 1 latency-associated transcript expression in trigeminal ganglia by in situ reverse transcriptase PCR. J Virol (1996) 1.06
The octamer binding protein Oct-2 inhibits transactivation of the herpes simplex virus immediate-early genes by the virion protein Vmw65. Virology (1993) 0.95
Neurons differentially control expression of a herpes simplex virus type 1 immediate-early promoter in transgenic mice. J Virol (1995) 0.93
Regulation of expression of the neuronal POU protein Oct-2 by nerve growth factor. J Biol Chem (1992) 0.92
The herpes simplex virus type 1 latency-associated transcript promoter is activated through Ras and Raf by nerve growth factor and sodium butyrate in PC12 cells. J Virol (1996) 0.91
Immunohistochemical identification of trigeminal ganglion neurons that innervate the mouse cornea: relevance to intercellular spread of herpes simplex virus. J Comp Neurol (1993) 0.86
Unusual abundance of atypical strains associated with human ocular toxoplasmosis. J Infect Dis (2001) 2.86
The progressive outer retinal necrosis syndrome. A variant of necrotizing herpetic retinopathy in patients with AIDS. Ophthalmology (1994) 2.25
Viral causes of the acute retinal necrosis syndrome. Am J Ophthalmol (2000) 1.91
Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis. Am J Ophthalmol (1998) 1.83
Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy. Clin Infect Dis (2000) 1.63
A latent, nonpathogenic HSV-1-derived vector stably expresses beta-galactosidase in mouse neurons. Neuron (1990) 1.57
Latent infection can be established with drastically restricted transcription and replication of the HSV-1 genome. Virology (1993) 1.48
Subretinal fibrosis in patients with Vogt-Koyanagi-Harada disease. Ophthalmology (2000) 1.47
Ocular manifestations of HIV infection. N Engl J Med (1998) 1.46
Cataract surgery with ciliary sulcus fixation of intraocular lenses in patients with uveitis. Am J Ophthalmol (1999) 1.38
Herpes simplex virus type 1 corneal infection results in periocular disease by zosteriform spread. J Virol (2001) 1.31
A sensitive and specific polymerase chain reaction-based assay for the diagnosis of cytomegalovirus retinitis. Am J Ophthalmol (1995) 1.28
Acquired immunodeficiency syndrome--associated herpes simplex virus retinitis. Clinical description and use of a polymerase chain reaction--based assay as a diagnostic tool. Arch Ophthalmol (1996) 1.26
The herpes simplex virus type 1 reactivation function lies outside the latency-associated transcript open reading frame ORF-2. J Virol (1993) 1.25
Polymerase chain reaction-based assays of vitreous samples for the diagnosis of viral retinitis. Use in diagnostic dilemmas. Ophthalmology (1998) 1.24
In vivo deletion analysis of the herpes simplex virus type 1 latency-associated transcript promoter. J Virol (1995) 1.20
A polymerase chain reaction-based assay for diagnosing varicella-zoster virus retinitis in patients with acquired immunodeficiency syndrome. Am J Ophthalmol (1997) 1.08
Effect of the transcription start region of the herpes simplex virus type 1 latency-associated transcript promoter on expression of productively infected neurons in vivo. J Virol (1994) 1.08
Ocular flora of patients with AIDS compared with those of HIV-negative patients. Cornea (1997) 1.05
Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains. Virology (2000) 1.03
Mooren ulcer in South India: serology and clinical risk factors. Am J Ophthalmol (1999) 1.01
Aspergillus fumigatus keratitis after laser in situ keratomileusis. Cornea (2001) 0.99
Ocular opportunistic infection incidences among patients who are HIV positive compared to patients who are HIV negative. Ophthalmology (1998) 0.98
Epidemiology and molecular analysis of herpes simplex keratitis requiring primary penetrating keratoplasty. Br J Ophthalmol (2004) 0.98
Ocular and sinus microsporidial infection cured with systemic albendazole. Am J Ophthalmol (1997) 0.95
Hypertensive iridocyclitis. Br J Ophthalmol (2006) 0.91
Bilateral surgically induced necrotising scleritis with secondary superinfection. Br J Ophthalmol (2005) 0.89
Corneal subepithelial infiltrate recurrence sine adenovirus. Cornea (1995) 0.89
Herpes simplex virus keratitis among patients who are positive or negative for human immunodeficiency virus: an epidemiologic study. Ophthalmology (1997) 0.89
Glycoprotein B subtyping of cytomegalovirus (CMV) in the vitreous of patients with AIDS and CMV retinitis. J Infect Dis (1998) 0.89
Functional maturation of the primate fetal adrenal in vivo: I. Role of insulin-like growth factors (IGFs), IGF-I receptor, and IGF binding proteins in growth regulation. Endocrinology (1996) 0.88
Bilateral angle closure glaucoma and accelerated cataract formation in a patient with AIDS. Br J Ophthalmol (1994) 0.88
A novel arginine substitution mutation in 1A domain and a novel 27 bp insertion mutation in 2B domain of keratin 12 gene associated with Meesmann's corneal dystrophy. Br J Ophthalmol (2004) 0.87
Fusarium and Acanthamoeba keratitis: can a single centre detect outbreaks? Br J Ophthalmol (2008) 0.87
Supratarsal injection of corticosteroid in the treatment of refractory vernal keratoconjunctivitis. Am J Ophthalmol (1996) 0.87
Ocular findings as a presenting sign of hydroa vacciniforme. Br J Ophthalmol (2004) 0.87
Microsporidial keratoconjunctivitis in a patient without human immunodeficiency virus infection. Am J Ophthalmol (1997) 0.86
Identification of bacterial pathogens in patients with endophthalmitis by 16S ribosomal DNA typing. Am J Ophthalmol (1999) 0.86
Disciform keratitis: a case of herpes zoster sine herpete. Am J Ophthalmol (1997) 0.85
Nocardia scleritis. Am J Ophthalmol (1997) 0.85
Cytomegalovirus-associated acute retinal necrosis syndrome. Am J Ophthalmol (1997) 0.84
Mutations in the cytomegalovirus UL97 gene associated with ganciclovir-resistant retinitis. J Infect Dis (1998) 0.84
Biotypes and serotypes of Haemophilus influenzae ocular isolates. Br J Ophthalmol (2002) 0.82
Chronic varicella-zoster virus epithelial keratitis in patients with acquired immunodeficiency syndrome. Arch Ophthalmol (1998) 0.81
HSV (type 1) infection of the trigeminal complex. Brain Res (1990) 0.80
Distribution of tumor necrosis factor receptor messenger RNA in normal and herpes simplex virus infected trigeminal ganglia in the mouse. Brain Res (1997) 0.80
Localization of tumor necrosis factor receptor messenger RNA in normal and herpes simplex virus-infected mouse eyes. Invest Ophthalmol Vis Sci (1997) 0.79
Response to hemorrhagic stress in the rhesus monkey fetus in utero: effects on the pituitary-adrenal axis. J Clin Endocrinol Metab (1993) 0.79
Prevalence of antiviral drug resistance in untreated patients with cytomegalovirus retinitis. J Infect Dis (2000) 0.79
Varicella zoster virus immune recovery stromal keratitis in a patient with AIDS. Br J Ophthalmol (2001) 0.79
Treatment of neurotrophic keratopathy with nasal dilator strips. Br J Ophthalmol (2005) 0.79
Advances in diagnosis and management of herpetic uveitis. Int Ophthalmol Clin (2000) 0.78
Microsporidial keratoconjunctivitis treated successfully with a short course of fumagillin. Eye (Lond) (1994) 0.78
Conjunctival lymphocytic nodule associated with the Epstein-Barr virus. Am J Ophthalmol (1991) 0.78
Uptake and anterograde axonal transport of wheat germ agglutinin from retina to optic tectum in the chick. J Cell Biol (1981) 0.78
Localization and regulation of corticotropin receptor expression in the midgestation human fetal adrenal cortex: implications for in utero homeostasis. J Clin Endocrinol Metab (1996) 0.78
Penicillin-resistant Streptococcus pneumoniae keratitis. Cornea (1996) 0.77
Rate of anterograde axonal transport of [125I]wheat germ agglutinin from retina to optic tectum in the chick. Brain Res (1981) 0.77
Functional maturation of the primate fetal adrenal in vivo. II. Ontogeny of corticosteroid synthesis is dependent upon specific zonal expression of 3 beta-hydroxysteroid dehydrogenase/isomerase. Endocrinology (1996) 0.76
Further evidence in support of the selective uptake and anterograde transport of [125I]wheat germ agglutinin by chick retinal ganglion cells. Brain Res (1984) 0.75
Varicella zoster virus ocular disease. Int Ophthalmol Clin (1998) 0.75